Streetbeat News

Stock Prices

ARBE

Arbe Robotics Ltd. (NASDAQ:ARBE) has released the production version of its Radar Processor, which boasts the strongest processing capabilities for automotive radars on the market. The processor can handle massive amounts of data with advanced hardware acceleration, supporting high-resolution range and AI perception capabilities. It is optimized for low power consumption and cost-effectiveness. Arbe's technology will be demonstrated at CES.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:11 pm

SCLX

Scilex Holding Company has announced an agreement to stock ELYXYB in over 500 stores of a leading U.S. pharmacy chain. The company is also negotiating with other major chains. ELYXYB is a non-opioid pain management product for acute migraine patients, offering pain relief in clinical studies within 15 minutes. More information is available on ELYXYB.com.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:09 pm

NVAX

Novavax Inc (NASDAQ:NVAX) stock is trading higher after the company's Covid-19 vaccine received Emergency Use Listing (EUL) from the World Health Organization (WHO) for individuals 12 years and older. The EUL facilitates expedited regulatory approvals for Novavax's vaccine in WHO's 194 member states. The vaccine's ease of transport and storage makes it suitable for rural or hard-to-reach areas, and it has shown to induce immune responses against multiple Covid variants.

Portfolio Pulse from Adam Eckert

November 28, 2023 | 2:08 pm

SPRC

SciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company, has adopted a limited duration shareholder rights plan to protect shareholder interests and prevent control or significant influence by entities through open-market accumulation without fair compensation. The Rights Plan is not a response to a specific takeover threat but aims to give the Board time to make informed decisions. Rights become exercisable if an entity acquires 10%+ of shares without Board approval, allowing other shareholders to buy shares at $0.001. The plan expires on November 27, 2024, and Meitar Law Offices is the legal counsel.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:06 pm

VEXTF

Vext Science, Inc. reported a challenging Q3 with an 11.8% drop in revenue to $8 million. Despite a year-over-year revenue increase of 5.5%, the company saw a significant decrease in gross profit and a net loss of $1.8 million. However, the company is optimistic about its expansion in Ohio's cannabis market, which is expected to grow to $4 billion in four years. Vext's stock traded lower after the report. The company remains focused on growth in Arizona and Ohio through 2024.

Portfolio Pulse from Jelena Martinovic

November 28, 2023 | 2:04 pm

BAC

COST

GLD

TGT

On CNBC's 'Halftime Report Final Trades,' analysts provided their recommendations on several stocks. Brian Belski of BMO Capital Markets highlighted Bank of America's (BAC) earnings and dividend yield. Costco (COST) was recommended by Jason Snipe, and Joseph Feldman maintained a $600 price target. Stephanie Link chose Target (TGT) after its strong quarterly results. Joseph Terranova selected SPDR Gold Shares (GLD) as gold prices rose. BAC shares fell, COST shares hit a new high, TGT shares slightly fell, and GLD shares gained.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 2:04 pm

ATNF

180 Life Sciences is reviewing strategic alternatives to enhance shareholder value. The company has not set a timeline for the completion of this review process.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:04 pm

CADL

Shares of Candel Therapeutics have been halted pending an announcement of news. Investors are awaiting the details of the news that prompted the trading halt.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:03 pm

ZS

Zscaler's stock price has declined following the release of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:03 pm

CMND

Clearmind Medicine shares have resumed trading. The company, possibly referenced as CMND in the article, had experienced a halt in trading prior to this announcement.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:02 pm